130 related articles for article (PubMed ID: 15769646)
21. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
Seo JH; Kim KW; Murakami S; Park BC
J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
[TBL] [Abstract][Full Text] [Related]
22. [Expression of mutant p53 in chronic HBV infection and hepatocellular carcinoma].
Chen Y; Tang ZY; Li J
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):184-7. PubMed ID: 7956695
[TBL] [Abstract][Full Text] [Related]
23. Early molecular and genetic determinants of primary liver malignancy.
Feitelson MA; Pan J; Lian Z
Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
[TBL] [Abstract][Full Text] [Related]
24. Effects of hepatitis B virus X protein on the development of liver cancer.
Zhang X; Zhang H; Ye L
J Lab Clin Med; 2006 Feb; 147(2):58-66. PubMed ID: 16459163
[TBL] [Abstract][Full Text] [Related]
25. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.
Wang H; Feng F; Wang XP; Wang RS; Wu Y; Zhu MG; Zhang H; Zhuang ZX
Mol Med Rep; 2016 Feb; 13(2):1077-82. PubMed ID: 26647961
[TBL] [Abstract][Full Text] [Related]
27. The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma.
Zhu M; London WT; Duan LX; Feitelson MA
Int J Cancer; 1993 Oct; 55(4):571-6. PubMed ID: 8406983
[TBL] [Abstract][Full Text] [Related]
28. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S
Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.
Liu J; Ahiekpor A; Li L; Li X; Arbuthnot P; Kew M; Feitelson MA
Int J Cancer; 2009 Oct; 125(8):1894-901. PubMed ID: 19610068
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
[TBL] [Abstract][Full Text] [Related]
31. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
32. [Immunohistochemical study on X antigen of HBV (HBxAg) in primary hepatic carcinoma].
Wang WL
Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):331-3. PubMed ID: 1337887
[TBL] [Abstract][Full Text] [Related]
33. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis.
Feitelson MA; Lee J
Cancer Lett; 2007 Jul; 252(2):157-70. PubMed ID: 17188425
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive regression analysis of hepatitis B virus X antigen level and anti-HBx antibody titer in the sera of patients with HBV infection.
Pál J; Nyárády Z; Marczinovits I; Pár A; Ali YS; Berencsi G; Kvell K; Németh P
Pathol Oncol Res; 2006; 12(1):34-40. PubMed ID: 16554914
[TBL] [Abstract][Full Text] [Related]
36. [Detection of HBxAg in liver specimens of patients with hepatocellular carcinoma].
Jin L
Zhonghua Bing Li Xue Za Zhi; 1990 Dec; 19(4):288-90. PubMed ID: 1964403
[TBL] [Abstract][Full Text] [Related]
37. Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.
Choi YM; Lee SY; Kim BJ
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704071
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of hepatitis B virus X antigen expression in chronic hepatitis B and cirrhosis].
Huang Y; Wu G; Wang X
Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):235-8. PubMed ID: 7587601
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma.
Feitelson MA; Zhu M; Duan LX; London WT
Oncogene; 1993 May; 8(5):1109-17. PubMed ID: 8386823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
